5 Einträge gefunden

1. AGO Algorithms for the Treatment of Breast Cancer: Update 2021

   1. Schneeweiss, Andreas
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Gerber, Bernd
   5. Jackisch, Christian
   6. Loibl, Sibylle
   7. Schmidt, Marcus

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Loibl, Sibylle
   4. Nekljudova, Valentina
   5. Weber, Karsten E
   6. Huober, Jens
   7. Fehm, Tanja

   2017 - Forschungsinformationssystem des UKE
3. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

   1. Müller, Volkmar
   2. Gade, Stephan
   3. Steinbach, Bettina
   4. Loibl, Sibylle
   5. von Minckwitz, Gunter
   6. Untch, Michael
   7. Schwedler, Kathrin

   2014 - Forschungsinformationssystem des UKE
4. Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).

   1. Loibl, Sibylle
   2. Müller, Volkmar
   3. von Minckwitz, Gunter
   4. Conrad, Bettina
   5. Koehne, Claus-Henning
   6. Kremers, Stephan
   7. Forstbauer, Helmut

   2011 - Forschungsinformationssystem des UKE
5. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

   1. Riethdorf, Sabine
   2. Müller, Volkmar
   3. Zhang, Liling
   4. Rau, Thomas
   5. Loibl, Sibylle
   6. Komor, Martina
   7. Roller, Marc

   2010 - Forschungsinformationssystem des UKE